-
2002
Company Description
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide.
-
Manufacturer:
Science and Engineering -
Formed:
2002 -
Company Website:
-
Company E-mail:
-
Company Address:
1301 Second Avenue, Suite 1900Seattle, WAUnited States -
CEO:
- Ryo Kubota
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits